Position in CRMD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$260,315
+$4,107 QoQ
Shares Held
38,338
+74.0% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WINTON GROUP Ltd holds $82,877,062 across 71 Biotechnology names. CRMD ranks #46 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
173,032 | $16,285,771 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,778 | $11,418,073 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
106,532 | $7,999,487 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
47,925 | $3,558,910 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
55,080 | $3,453,516 | |
| 6 | VIR |
Vir Biotechnology, Inc.
|
367,883 | $3,296,231 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
307,096 | $2,892,844 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
69,291 | $2,787,576 |
All Filings in CRMD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $260,315 | 38,338 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $256,208 | 22,030 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $295,948 | 25,447 | Shares | Sole | 2025-11-13 | |
| 2020-09-30 | $376,603 | 62,455 | Shares | Sole | 2020-10-30 | |
| No filing history on record for this holder in this stock. | ||||||